Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01073943 · ClinicalTrials.gov registry record · Phase 3
Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Day Before PicoPrep
A Phase 3 study, sponsored by Ferring Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 603
- Enrollment target
NCT01073943 is a Phase 3 study that has completed, run by Ferring Pharmaceuticals. The registered enrollment target is 603 participants.
The verdict
NCT01073943, a Phase 3 study, has completed, sponsored by Ferring Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 603 participants
- Enrollment target
Study Summary
Subjects undergoing an elective complete colonoscopy will randomly receive either PicoPrep: 2-sachets for oral solution in two divided doses given in the afternoon (first dose - sachet) and 6 hours later in the evening (second dose - sachet), given the day before the procedure or HalfLytely: for oral solution and two 5 mg Bisacodyl tablets, given the day before the procedure to evaluate its effectiveness, tolerability and safety.
Interventions
- DRUG PicoPrep
- DRUG HalfLytely
- DRUG bisacodyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 603 participants |
| Start Date | 2010-05 |
| Est. Completion | 2010-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01073943
The ClinicalTrials.gov registry entry for NCT01073943 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 603 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ferring Pharmaceuticals, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PicoPrep is the first listed.
NCT01073943 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01073943 about?
NCT01073943 is a clinical study titled "Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Day Before PicoPrep". Subjects undergoing an elective complete colonoscopy will randomly receive either PicoPrep: 2-sachets for oral solution in two divided doses given in the afternoon (first dose - sachet) and 6 hours later in the evening (second dose - sachet), given the day before the procedure or HalfLytely: for ora...
What is the current status of trial NCT01073943?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 603 participants. The study started on 2010-05. Estimated completion is 2010-10.
What interventions are being tested in trial NCT01073943?
The interventions under investigation include: PicoPrep (DRUG), HalfLytely (DRUG), bisacodyl (DRUG).
Who is sponsoring clinical trial NCT01073943?
This trial is sponsored by Ferring Pharmaceuticals, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.